Child has taken a stimulant MPH an amphetamine preparation or pemoline alpha-adrenergic clonidine or guanfacine or other ADHD medication within 2 weeks of the screening telephone interview Children will not be withdrawn from psychotropic medications in order to be enrolled in the study 